| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Fiscal Year 2025 GuidanceGuidance reflects the full year impact of approximately $150 million from lower-than-expected risk adj...
Agilon Health (NYSE:AGL) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.16) ...
Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and lowers the price target from $5 ...
Bernstein analyst Lance Wilkes downgrades Agilon Health (NYSE:AGL) from Outperform to Market Perform and lowers the price ta...
Jefferies analyst Jack Slevin maintains Agilon Health (NYSE:AGL) with a Hold and lowers the price target from $2.4 to $1.1.